Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 21, Number 1—January 2015
Dispatch

Characterization of a Multidrug-Resistant, Novel Bacteroides Genomospecies

Stephen J. Salipante1, Aley Kalapila1, Paul S. Pottinger, Daniel R. Hoogestraat, Lisa Cummings, Jeffrey S. Duchin, Dhruba J. Sengupta, Steven A. Pergam, Brad T. Cookson, and Susan M. Butler-WuComments to Author 
Author affiliations: University of Washington, Seattle, Washington, USA (S.J. Salipante, A. Kalapila, P.S. Pottinger, D.R. Hoogestraat, L. Cummings, J.S. Duchin, D.J. Sengupta, S.A. Pergam, B.T. Cookson, S.M. Butler-Wu); Fred Hutchinson Cancer Research Center, Seattle (A. Kalapila, S.A. Pergam)

Main Article

Table

Antimicrobial susceptibility results for a novel Bacteroides genomospecies isolated from the bloodstream and intraabdominal abscesses of a patient with colon cancer, 2013

Antimicrobial drug MIC, μg/mL*
Ampicillin/sulbactam >256/128
Cefotetan 64
Clindamycin >256
Imipenem >32†
Linezolid 2
Metronidazole >256†
Minocycline 4
Moxifloxacin >32
Piperacillin/tazobactam >256
Synercid >32
Tetracycline 16
Ticarcillin/clavulanic acid >256/2
Tigecycline 1

*Antimicrobial susceptibility testing performed by using E-test (Technical Appendix).
†MICs confirmed as >64 μg/mL by macrobroth dilution.

Main Article

1These first authors contributed equally to this article.

Page created: December 19, 2014
Page updated: December 19, 2014
Page reviewed: December 19, 2014
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external